Tech Company Financing Transactions

Avera Pharmaceuticals Funding Round

On 3/31/2006, Avera Pharmaceuticals landed $18 million in funding from Aberdare Ventures, Bay City Capital and Frazier Healthcare Partners.

Transaction Overview

Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$17,999,700
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4350 La Jolla Village Dr. 450
San Diego, CA 92122
USA
Email Address
Overview
Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses.
Profile
Avera Pharmaceuticals LinkedIn Company Profile
Social Media
Avera Pharmaceuticals Company Twitter Account
Company News
Avera Pharmaceuticals News
Facebook
Avera Pharmaceuticals on Facebook
YouTube
Avera Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dinu Sen
  Dinu Sen LinkedIn Profile  Dinu Sen Twitter Account  Dinu Sen News  Dinu Sen on Facebook
Chief Medical Officer
Barney King
  Barney King LinkedIn Profile  Barney King Twitter Account  Barney King News  Barney King on Facebook
Chief Scientific Officer
William Pitlick
  William Pitlick LinkedIn Profile  William Pitlick Twitter Account  William Pitlick News  William Pitlick on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2006: Ambarella venture capital transaction
Next: 3/31/2006: Cohorts venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary